Research in Kirkland
Science Explorer records 3 research institutions in Kirkland, Canada. The largest by output are Merck Canada Inc. (Canada), Pfizer (Canada) and Zoetis (Canada).
- Research institutions
- 3
- Research works
- 1.5k ▼ 9% vs 2013–17
- Top-10% rate, 2022–2025
- 16.8% record average 16.5%
A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.
Which research institutions are in Kirkland?
| # | Institution | Works | Against the largest here | World rank |
|---|---|---|---|---|
| 1 | Merck Canada Inc. (Canada)Company | 1,313 | #4,216 all time | |
| 2 | Pfizer (Canada)Company | 188 | #29,333 all time | |
| 3 | Zoetis (Canada)Company | 6 | not ranked |
By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.
Which keywords describe research in Kirkland?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Antimicrobial Resistance, Vaccine Development, Disease Burden, Human Metapneumovirus, Respiratory Syncytial Virus, Clinical Practice Guidelines and Antibiotic Resistance.
- Inflammatory Bowel Disease
- Inhibitors
- Financial Toxicity
- Cost of Care
- Disease-Modifying Antirheumatic Drugs
- Biological Therapy
- Prophylaxis
- Cytokines
- Health Utility Measures
- Cardiovascular Risk
- Metallurgy
- Gene Therapy
- ESKAPE Pathogens
- Quality of Life
- Community-Acquired Pneumonia
- Pathogenesis
- Clinical Practice Guidelines
- Respiratory Syncytial Virus
- Disease Burden
- Antimicrobial Resistance
- Epidemiology
- Vaccine Development
- Human Metapneumovirus
- Inflammation
- Antibiotic Resistance
- Respiratory Infections
- Pneumococcal Conjugate Vaccine
- Vaccine
- Multidrug-Resistant Bacteria
- Infectious Diseases
- Autoantibodies
- Cost-effectiveness Analysis
- Rheumatoid Arthritis
- Drug Resistance
- Antibiotic Pharmacokinetics
- Critically Ill Patients
- Safety
- Factor VIII
- Hemophilia
- Global Health
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology21▲ 4.9×47 topics
- Antimicrobial Resistance7▲ 32×6 topics
- Vaccine Development6▲ 23×5 topics
- Disease Burden6▲ 71×2 topics
- Human Metapneumovirus6▲ 112×1 topic
- Respiratory Syncytial Virus6▲ 112×1 topic
- Inflammation5▲ 2.2×19 topics
- Clinical Practice Guidelines5▲ 7.8×7 topics
- Antibiotic Resistance4▲ 11×6 topics
- Pathogenesis4▲ 7.8×11 topics
- Respiratory Infections4▲ 31×2 topics
- Community-Acquired Pneumonia4▲ 105×1 topic
- Pneumococcal Conjugate Vaccine4▲ 105×1 topic
- Quality of Life4▲ 2.3×9 topics
- Vaccine2▲ 5.7×7 topics
- ESKAPE Pathogens2▲ 38×1 topic
- Multidrug-Resistant Bacteria2▲ 38×1 topic
- Gene Therapy2▲ 11×4 topics
- Infectious Diseases2▲ 6.5×5 topics
- Metallurgy2▲ 36×2 topics
- Autoantibodies2▲ 8.6×5 topics
- Cardiovascular Risk2▲ 6.6×4 topics
- Cost-effectiveness Analysis2▲ 24×1 topic
- Health Utility Measures2▲ 24×1 topic
- Rheumatoid Arthritis2▲ 20×3 topics
- Cytokines2▲ 6.7×2 topics
- Drug Resistance2▲ 6.7×2 topics
- Prophylaxis2▲ 15×3 topics
- Antibiotic Pharmacokinetics2▲ 59×1 topic
- Biological Therapy2▲ 32×1 topic
- Critically Ill Patients2▲ 59×1 topic
- Disease-Modifying Antirheumatic Drugs2▲ 36×1 topic
- Safety2▲ 73×2 topics
- Cost of Care2▲ 56×1 topic
- Factor VIII2▲ 117×1 topic
- Financial Toxicity2▲ 56×1 topic
- Hemophilia2▲ 117×1 topic
- Inhibitors2▲ 41×2 topics
- Global Health2▲ 10×2 topics
- Inflammatory Bowel Disease2▲ 14×4 topics
What research is done in Kirkland?
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Respiratory viral infections research Epidemiology 6 works
- 2 Pneumonia and Respiratory Infections Epidemiology 4 works
- 3 Antibiotic Resistance in Bacteria Molecular Medicine 2 works
- 4 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
- 5 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
- 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 2 works
- 7 Economic and Financial Impacts of Cancer Economics and Econometrics 2 works
- 8 Hemophilia Treatment and Research Hematology 2 works
- 9 Spondyloarthritis Studies and Treatments Rheumatology 2 works
- 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 2 works
Research output over time
The same series as a ribbon — one cell per year, darker for more.